Liver-eye axis in metabolic syndrome: integrated evidence from mendelian randomization, single-cell sequencing, and clinical sample validation
Tian-Hao Yuan, Yi-Fan Fang, Guo-Heng Zhang, Hao-Rui Zhang, Zi-Yi Zhou, Zhen-Sheng Yue, Bei Li, Lin Wang, Yu-Sheng Wang, Guo-Rui Dou · 2026
Read Liver-eye axis in metabolic syndrome: integrated evidence from mendelian randomization, single-cell sequencing, and clinical sample validation by Tian-Hao Yuan, Yi-Fan Fang, Guo-Heng Zhang, Hao-Rui Zhang, Zi-Yi Zhou, Zhen-Sheng Yue, Bei Li, Lin Wang, Yu-Sheng Wang, Guo-Rui Dou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13597407.txt.
Description
Tian-Hao Yuan and nine co-authors test whether fatty liver disease drives diabetic eye disease. Their 2026 study links two common harms of metabolic syndrome. One scars the liver; the other blinds through retinal damage. Whether one causes the other has stayed unsettled.
Genetic tools stood in for lifelong exposure in a Mendelian randomization design. Blood protein data from three sources joined the search for middlemen. Candidate proteins were then checked in liver cells one by one. Patient blood and eye fluid samples confirmed the levels. The chain from liver to eye gained concrete protein links. Treating the liver might one day protect the eyes as well.
Catalog record
| CREATOR | Tian-Hao Yuan, Yi-Fan Fang, Guo-Heng Zhang, Hao-Rui Zhang, Zi-Yi Zhou, Zhen-Sheng Yue, Bei Li, Lin Wang, Yu-Sheng Wang, Guo-Rui Dou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |